TBC1D15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.498200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.287400E-01
Normal-vs-Stage2
9.580200E-01
Normal-vs-Stage3
1.366960E-01
Normal-vs-Stage4
5.301400E-01
Stage1-vs-Stage2
3.402600E-01
Stage1-vs-Stage3
1.300620E-01
Stage1-vs-Stage4
9.886400E-01
Stage2-vs-Stage3
2.152600E-01
Stage2-vs-Stage4
4.394600E-01
Stage3-vs-Stage4
4.893900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.344600E-01
Normal-vs-AfricanAmerican
7.071200E-01
Normal-vs-Asian
5.894600E-01
Caucasian-vs-AfricanAmerican
3.825800E-01
Caucasian-vs-Asian
3.954800E-01
AfricanAmerican-vs-Asian
2.565400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.472600E-01
Normal-vs-Female
9.587400E-01
Male-vs-Female
9.581000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.280600E-01
Normal-vs-Age(41-60Yrs)
6.852600E-01
Normal-vs-Age(61-80Yrs)
7.781400E-01
Normal-vs-Age(81-100Yrs)
6.656000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.427800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.944600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.318600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.289660E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.175210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.609200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.473800E-01
Normal-vs-Daily Drinker
2.762000E-01
Normal-vs-Weekly Drinker
6.490800E-01
Normal-vs-Occasional Drinker
6.501800E-01
Normal-vs-Social Drinker
9.728800E-01
Non Drinker-vs-Daily Drinker
4.042200E-01
Non Drinker-vs-Weekly Drinker
9.387600E-01
Non Drinker-vs-Occasional Drinker
4.227900E-02
Non Drinker-vs-Social Drinker
3.103600E-01
Daily Drinker-vs-Weekly Drinker
5.297400E-01
Daily Drinker-vs-Occasional Drinker
9.815500E-03
Daily Drinker-vs-Social Drinker
1.483620E-01
Weekly Drinker-vs-Occasional Drinker
1.294960E-01
Weekly Drinker-vs-Social Drinker
4.452600E-01
Occasional Drinker-vs-Social Drinker
4.810800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.779820E-01
Normal-vs-Grade 2
8.778100E-02
Normal-vs-Grade 3
6.604000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.002200E-01
Grade 1-vs-Grade 3
7.705400E-01
Grade 1-vs-Grade 4
1.779820E-01
Grade 2-vs-Grade 3
7.852000E-01
Grade 2-vs-Grade 4
8.778100E-02
Grade 3-vs-Grade 4
6.604000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.796400E-01
Normal-vs-NonDiabetic
7.103800E-01
Diabetic-vs-NonDiabetic
5.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.232200E-01
Normal-vs-NoPancreatitis
8.603400E-01
Pancreatitis-vs-NoPancreatitis
1.353840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.516800E-01
Normal-vs-N1
9.632600E-01
N0-vs-N1
9.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.632000E-01
Normal-vs-TP53-NonMutant
8.473600E-01
TP53-Mutant-vs-TP53-NonMutant
4.139400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
